Bacterial multiplication in the lung associated with murine Sendai virus pneumonia is caused by virus-induced defects in pulmonary bactericidal mechanisms. The nature of this effect has been studied in animals immunized against the challenge bacteria. Mice were immunized against Proteus mirabilis by intraperitoneal inoculation and by aerosol inhalation. After the development of immunity, mice were infected aerogenically with 10 4 TCID 50 of Sendai virus. 7 days later, during the height of the bronchial inflammation and pulmonary consolidation, the mice were challenged with an aerosol of viable 35 S-labeled Proteus mirabilis or 32 P-labeled Staphylococcus aureus.
INTRODUCTION
Pulmonary virus infections often predispose to bacterial infections in the lung and contribute to the morbidity Presented in part at the 72nd Annual Meeting of the American Society for Microbiology in Philadelphia, Pa., 25 April 1972.
Received for publication 13 October 1972 and in revised form 17 July 1973. and mortality of acute and chronic respiratory illnesses (1, 2) . The mechanisms of these viral-bacterial interactions has been studied in a model of combined Sendai virus and staphylococcal infection in the lung. Mice infected with Sendai virus develop extensive desquamative lesions of the bronchial epithelium and consolidation in the lung parenchyma (3) . This pathology resembles closely that induced by influenza virus infection in man (4) . Quantitative measurement of bactericidal and transport defense mechanisms in the lung during virus pneumonia has shown that during limited time periods of the virus infection, severe defects are produced in the in situ bactericidal (phagocytic) mechanism of the lung, but that despite histologic evidence of extensive destruction of bronchial-ciliated epithelium, the transport mechanisms of the lung remain intact (3, 5) .
Aerosol immunization with Sendai virus protects animals against subsequent viral challenge and thus prevents the virus-induced suppression of pulmonary bactericidal activity (6) . In the series of experiments reported here, further support for the concept of a virusinduced phagocytic defect in the lung was sought by examination of the effects of bacterial immunization on these virus bacterial interactions. Immunization against the challenge bacterial strain should enhance phagocytosis of the challenge organism on subsequent exposure. What effect this immunization would have in immune animals subsequently infected with Sendai virus is unknown and is the subject of the following report. For immunization by aerosol, the washed and concentrated suspension was used live. The bacterial suspension contained approximately 10's organisms per milliliter. Animals were exposed to an aerosol of this suspension for 2 h in a previously described exposure chamber (3) ; 30 ml of the suspension was nebulized during this period and animals inhaled approximately 108 organisms.
METHODS
Preparation of bacterial aerosols. P. mirabilis and Staphylococcus aureus (coagulase-positive FDA strain 209P, phage type 42D) were labeled with 'S and 'P, respectively, by the method of Green and Green (7) , and Green and Goldstein (8) . In brief, S. aureus and P. mirabilis were incubated in 70 ml of phosphorus-free and sulfur-free culture medium containing 1.0 mCi of either 'P or "S. After 18 h of growth at 370C in a rotating shaker water bath, the labeled cells were centrifuged separately, washed twice in 30 ml of phosphate buffer (pH 7.4) to remove all unattached label, and suspended in 8 ml of TS broth.
Animal exposure. 9 days after immunization, control animals and immunized animals were infected by aerosol with a sublethal 10' TCIDro of Sendai virus. 7 days later the animals were challenged for 30 min with 'S-labeled P. mirabilis or 32P-labeled S. autreus. Bacterial and radiotracer concentrations in the animal exposure chamber were sampled by previously described methods (3).
Bacteriologic and radioassay procedures. At 0, 1, 2, 3, 4, and 24 h after aerosol exposure, groups of six to nine mice were killed by cervical dislocation. The lungs were removed aseptically by transection of the mainstem bronchi, washed with sterile phosphate buffer, and carefully checked for surface consolidation. Lungs were homogenized in 3 ml of TS broth. 1 ml of the homogenate was diluted appropriately and cultured quantitatively in quadruplicate on Petri x-plates by the standard dilution pour-plate technique.
P. snirabilis and S. auireuts were cultured respectively on bismuth sulfite and phenylethanol agar.
Calculation of pulmonary antibacterial activity. Pulmonary bactericidal activity, defined as the change in the proportion of viable to total bacteria, was calculated in each individual animal by the radioactive ratio method of Green and Goldstein (8) . The ratio of radioactive counts was determined for the organism in the aerosol and in the lungs. Bactericidal activity was calculated from the change that occurred between the two ratios and is expressed as a percentage of the ratio in the aerosol as follows: Percent bacteria remaining = Bact. count Radiotracer count (lg) Bact. count Radiotracer count (aerosol) X 100 = Ratio (lung) X 100.
Ratio (aerosol)
This method calculates bactericidal activity of the lung as a function independent of the number of inhaled organisms.
Calculation of physical transport activity. Physical transport of 'S-labeled P. mirabilis from the lungs was determined by following the decline in radiotracer activity. The 'S counts were expressed as the percentage of the initial radiotracer counts recovered.
Serology. Blood was collected by axillary bleeding from approximately one-third of the animals in each group. Bacterial agglutination tests for the detection of serum agglutinins against P. mirabilis were determined by standard methods (9) .
Statistical determinations. The data were analyzed by determining the arithmetic means, standard deviations (SD) and standard errors (SE) for each group and comparisons between groups were made according to the two independent sample t tests.
Histology. Histologic studies on the lungs of test animals were not possible, the entire lung being used for quantitation. Separate groups of mice, concurrently exposed, were used for study of pulmonary histology. The lungs of these mice were fixed in 10% buffered formalin, sectioned at 5 um and stained with hematoxylin and eosin.
RESULTS

Bacterial deposition. Initial intrapulmonary retention
of aerosolized 'S-labeled P. mirabilis was quantified in nonimmune animals and animals immunized aerogenically against P. mirabilis and subsequently infected with Sendai virus by aerosol or left uninfected as controls (Table I). As shown in Table I there was no consistent effect of either the immunization or the virus infection on the numbers of viable organisms or radiotracer labeled counts recovered immediately after the aerosol exposure (P > 0.05 for viable bacteria and radiotracer counts between pairs of the four groups). These data show that neither virus infection, immunization nor the combination significantly affected the initial deposition of infectious bacterial particles in the lungs.
Effect of immunization on pulnonary defenses. The effect of immunization against the P. mirabilis on intrapulmonary bactericidal activity and radiotracer label clearance was studied over the first 4 postexposure h. As shown in Fig. 1 , immunization enhanced pulmonary bactericidal activity but had no effect on particle trans- particle uptake in a phagocytic mechanism in the distal \ lung.
These studies were extended from 4 to 24 h in an ad-, j 0 ditional set of experiments shown in Fig. 2 Table II and Fig. 3 will confirm the vast differences in pulmonary bactericidal activity in virus-infected mouse lungs between nonimmune and immunized groups.
The effect of aerogenic immunization with P. mirabilis on intrapulmonary bactericidal activity against a heterologous organism, S. aurcus, was also studied in virusinfected mice assayed at 0, 4, and 24 h after challenge with 32P-labeled S. aurcus. As shown in Fig. 4 , im- 25-50% of the lung 7 days after Sendai virus infection. The extent of these pulmonary changes was similar in nonimmunized and immunized mice, and within the same lung, ranged from partial to essentially complete consolidation involving parts or the whole of one or more lobes. 24 h after aerosol challenge with P. mirabilis, surface consolidation in nonimmunized animals increased approximately twofold over that observed in lungs of animals sacrificed at 4 h after bacterial challenge. No such increases in the total amount of surface consolidation was observed in immunized animals. The microscopic pathology of the lungs 7 days after virus infection ranged from areas of seemingly uninvolved lung tissue to areas of bronchial epithelial cell desquamation, interstitial pneumonitis, and dense pneumonic consolidation. No discernible differences in microscopic pulmonary changes were observed between lung sections of nonimmunized and immunized animals.
DISCUSSION
Previous studies have shown that virus infection paralyzes pulmonary bactericidal activity in the first 4 h after infection (3) . The data in Fig. 3 show that the result of this paralysis in nonimmunized animals is bacterial multiplication. By contrast, animals immunized by the aerosol route showed essentially normal bactericidal activity. By comparing the ratio values in the animals killed at 24 h with the ratio values from the initial infective aerosol, it was determined that about 1% of the original challenge inoculum remained viable in the virus-infected immunized animals at 24 h. The findings in the i.p. immunized animals were of interest in that although variation was considerable in this group the mean result was that no net change in bacterial numbers took place from 4 to 24 h. This finding suggested a bacteriostatic effect in the lung in which either bacteria neither multiplied nor were killed or multiplication and killing were evenly balanced.
Influenza (5), Reovirus (10), and Sendai virus (3) infections of mice are known to suppress pulmonary antibacterial activity 6-10 days after inoculation of the virus. This impairment of bactericidal activity is temporally associated with: (a) rapidly declining pulmonary virus titers, (b) the appearance of serum antibody, and (c) pulmonary histologic changes marked by bronchial epithelial cell destruction, edema, and consolidation. A recent finding from this laboratory shows that this impairment of host resistance during virus infection is mediated through a defect in in situ bactericidal mechanisms rather than through a defect in the mucociliary or alveolar transport systems (3) . The data in this report indicate that virus-induced depression of bactericidal ac- The best available experimental data indicate that the bactericidal functions of the lung depend on the phagocytic capacity of the alveolar macrophages to kill, inactivate, or limit the growth of infectious organisms (11) . In the experiments reported here, immunization by parenteral and respiratory routes against the homologous challenge organism significantly enhanced the pulmonary bactericidal activity. This immune-induced accelerated bactericidal activity further supports the hypothesis that phagocytosis is responsible for bactericidal activity since phagocytic enhancement is a known effect of specific immunization (12) , whereas no mechanism of immune enhancement of bronchopulmonary transport systems has been described. Although immune enhancement of phagocytosis has been demonstrated primarily with peritoneal macrophages, recent studies suggest that particle uptake by alveolar macrophages is also accelerated by previous immunization (13, 14) ; however, these latter observations require further documentation.
Immunologic measurements were limited to serum antibody titrations during the course of these studies. The lack of a nonspecific effect against a heterologous organism, however, indicates that specific immunologic mechanisms were involved in the enhancement of intrapulmonary killing and the prevention of the virus-induced inhibition of pulmonary bactericidal activity. The lack of a nonspecific effect against S. aureus and the magnitude of the specific effect against P. mirabilis rules out the possibility that enhancement of pulmonary bactericidal activity was due to a nonspecific effect of particulate inhalation (15) brought about by the aerogenic immunization procedure.
The mechanism of immune enhancement of pulmonary bactericidal activity is not known; however, we speculate that it relates to the development of local antibody and cellular immunity. The induction of a state of local immunity in aerogenically immunized mice is suggested by the enhanced bactericidal activity in the absence of serum antibody. Resistance to virus infection correlates positively with immunoglobulin titers in bronchial washings, but varies independently of serum antibody titers (16) (17) (18) . With bacteria, local and parenteral vaccination of rabbits with Pseudornonas aceruginosa has been shown to induce IgG in bronchial secretions. These globulins opsonize P. aeruginosa in vitro and enhance particle-uptake but have no effect on intracellular digestion. By analogy, the presence of opsonizing antibody in the lung, at the site of alveolar macroplhage activity, should be very effective in enhancing the phagocytic activity of the pulmonary macrophage. The (19) (20) (21) . Intranasal immunization has been demonstrated to induce cellular immunity in the lungs (22, 23) and cellular immunity is known to lead to macrophage activation (24, 25) . On the other hand, the induction of pulmonary cell-mediated immunity by parenteral immunization has been found to be dose dependent (22) and vary with the route of immunization (26) .
Whether a localized cellular immune response was elicited by i.p. immunization with killed P. mirabilis remains to be determined. However, the studies performed in nonvirus-infected mice suggest that local immunity, either humoral or cellular or both, plays an important role in the immune enhancement of pulmonary bactericidal activity.
These studies, although applied to an experimental model, are important as a contribution to the relatively undeveloped area of local immunity to respiratory infections. The role of secretory antibodies in respiratory disease has received much attention lately (27) . However, these studies have primarily stressed viral vaccines (28, 29) . On the other hand, studies on local cellular immunity have been performed primarily with intrac'Ilular parasites such as Mycobacterium tuberculosis (30, 31) and Listeria mnonocytogenes (20) , but local immunity against potential bacterial pathogens, whether humoral or cellular, has not received equal attention. Our experiments with P. mirabilis were performed primarily to determine the specific and nonspecific effects of immunization on viral-bacterial interactions in the lung. These studies clearly demonstrate that local immunization prevented the virus-induced defect in pulmonary bactericidal mechanisms against the homologous challenge organism.
